Rifabutin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

NON-FDA APPROVED USES

  • Treatment of disseminated MAC in pts with AIDS (in combination with macrolide plus ethambutol).
  • Treatment of TB in pts with AIDS who are taking PIs or NNRTIs.
  • Treatment of latent TB in pts intolerant to INH. Rifabutin x 4 months can be considered.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: February 1, 2016

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Rifabutin ID - 540482 A1 - Bartlett,John,M.D. AU - Pham,Paul,Pharm.D. Y1 - 2016/02/01/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540482/all/Rifabutin PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -